Media Contact: Shantell Kirkendoll 734-764-2220

University of Michigan Health System launches plan for new hybrid operating room

ANN ARBOR, Mich. -- The University of Michigan Frankel Cardiovascular Center will launch plans to build a new state-of-the-art  hybrid operating room to offer life-saving alternatives to open heart surgery.

The University of Michigan Board of Regents approved the $14.8 million project Thursday which will be funded by the U-M Hospitals and Health Centers and gained support from a major gift to the Victors for Michigan campaign from University alumni Bob and Ann Aikens, of Bloomfield Hills, Mich.

Hybrid operating rooms have flexible uses and enable the minimally invasive repair of heart valves and treatment of arrhythmias, aortic aneurysms and coronary arteries. Patients, especially the elderly, have shorter hospital stays and recover more quickly from less invasive procedures.

UMHS hybrid OR

The newest hybrid surgical suite, which is twice the size of a regular OR, merges the radiological and surgical techniques that make advanced hybrid procedures possible. The facilities are considered an essential part of any state-of-the-art cardiovascular program.

It is expected to open in spring 2017, pending approval of a certificate of need from the Michigan Department of Community Health.

A dramatic shift in cardiovascular care supports catheter-based procedures and the U-M Frankel Cardiovascular Center has been a key player in that treatment transformation.

Catheter-based interventions rely on tiny tubes to reach the chambers of the heart rather than open heart surgery and have allowed many people too old, frail or at high or intermediate surgical risk to get help for severe heart problems.

U-M interventional cardiologists and surgeons are national leaders in performing a transcatheter technique to replace the failing aortic valves of patients who cannot tolerate open heart surgery.

The University of Michigan Frankel Cardiovascular Center has performed more than 500 transcatheter aortic valve replacements, known as TAVR, which is more than any other hospital in Michigan. The U-M participates in national clinical trials to test next-generation devices and techniques.

NOTICE: Except where otherwise noted, all articles are published under a Creative Commons Attribution 3.0 license. You are free to copy, distribute, adapt, transmit, or make commercial use of this work as long as you attribute Michigan Medicine as the original creator and include a link to this article.

Media Inquiries:  734-764-2220 8 a.m.-5 p.m. ET 

734-936-4000 after hours, weekends, and holidays (ask for the PR person on call) for embargoed news, videos & more